201 related articles for article (PubMed ID: 33583367)
1. Novel Biomarkers for Lupus Nephritis in the "OMICS" Era.
Dias R; Hasparyk UG; Lopes MP; de Barros JLVM; Simões E Silva AC
Curr Med Chem; 2021; 28(29):6011-6044. PubMed ID: 33583367
[TBL] [Abstract][Full Text] [Related]
2. Proximity extension assay proteomics and renal single cell transcriptomics uncover novel urinary biomarkers for active lupus nephritis.
Li Y; Tang C; Vanarsa K; Thai N; Castillo J; Lea GAB; Lee KH; Kim S; Pedroza C; Wu T; Saxena R; Mok CC; Mohan C
J Autoimmun; 2024 Feb; 143():103165. PubMed ID: 38194790
[TBL] [Abstract][Full Text] [Related]
3. Proteomic analysis in lupus mice identifies Coronin-1A as a potential biomarker for lupus nephritis.
Nicolaou O; Sokratous K; Makowska Z; Morell M; De Groof A; Montigny P; Hadjisavvas A; Michailidou K; Oulas A; Spyrou GM; Demetriou C; Alarcón-Riquelme ME; Psarellis S; Kousios A; Lauwerys B; Kyriacou K
Arthritis Res Ther; 2020 Jun; 22(1):147. PubMed ID: 32552896
[TBL] [Abstract][Full Text] [Related]
4. Update on Novel Blood-Based Biomarkers for Lupus Nephritis Beyond Diagnostic Approaches.
Maravillas-Montero JL; Reyes-Huerta RF
Rev Invest Clin; 2022; 74(5):227-231. PubMed ID: 36327996
[TBL] [Abstract][Full Text] [Related]
5. Integrative analysis of COL6A3 in lupus nephritis: insights from single-cell transcriptomics and proteomics.
Mou L; Zhang F; Liu X; Lu Y; Yue M; Lai Y; Pu Z; Huang X; Wang M
Front Immunol; 2024; 15():1309447. PubMed ID: 38855105
[TBL] [Abstract][Full Text] [Related]
6. Urinary angiostatin, CXCL4 and VCAM-1 as biomarkers of lupus nephritis.
Mok CC; Soliman S; Ho LY; Mohamed FA; Mohamed FI; Mohan C
Arthritis Res Ther; 2018 Jan; 20(1):6. PubMed ID: 29325582
[TBL] [Abstract][Full Text] [Related]
7. Deep Phenotyping of Urinary Leukocytes by Mass Cytometry Reveals a Leukocyte Signature for Early and Non-Invasive Prediction of Response to Treatment in Active Lupus Nephritis.
Bertolo M; Baumgart S; Durek P; Peddinghaus A; Mei H; Rose T; Enghard P; Grützkau A
Front Immunol; 2020; 11():256. PubMed ID: 32265898
[TBL] [Abstract][Full Text] [Related]
8. The role of non-coding RNA in lupus nephritis.
Liang H; Liu Q
Hum Cell; 2023 May; 36(3):923-936. PubMed ID: 36840837
[TBL] [Abstract][Full Text] [Related]
9. Biomarker profiling for lupus nephritis.
Li Y; Fang X; Li QZ
Genomics Proteomics Bioinformatics; 2013 Jun; 11(3):158-65. PubMed ID: 23732627
[TBL] [Abstract][Full Text] [Related]
10. Discovery and Qualification of Candidate Urinary Biomarkers of Disease Activity in Lupus Nephritis.
Anania VG; Yu K; Pingitore F; Li Q; Rose CM; Liu P; Sandoval W; Herman AE; Lill JR; Mathews WR
J Proteome Res; 2019 Mar; 18(3):1264-1277. PubMed ID: 30525646
[TBL] [Abstract][Full Text] [Related]
11. Utility of urinary transferrin and ceruloplasmin in patients with systemic lupus erythematosus for differentiating patients with lupus nephritis.
Urrego T; Ortiz-Reyes B; Vanegas-García AL; Muñoz CH; González LA; Vásquez G; Gómez-Puerta JA
Reumatol Clin (Engl Ed); 2020; 16(1):17-23. PubMed ID: 29530762
[TBL] [Abstract][Full Text] [Related]
12. Clinical application of protein biomarkers in lupus erythematosus and lupus nephritis.
Qi S; Chen Q; Xu D; Xie N; Dai Y
Lupus; 2018 Sep; 27(10):1582-1590. PubMed ID: 29720035
[TBL] [Abstract][Full Text] [Related]
13. High-Throughput Sequencing Reveals Circulating miRNAs as Potential Biomarkers of Kidney Damage in Patients with Systemic Lupus Erythematosus.
Navarro-Quiroz E; Pacheco-Lugo L; Lorenzi H; Díaz-Olmos Y; Almendrales L; Rico E; Navarro R; España-Puccini P; Iglesias A; Egea E; Aroca G
PLoS One; 2016; 11(11):e0166202. PubMed ID: 27835701
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-32γ: Possible association with the activity and development of nephritis in patients with systemic lupus erythematosus.
Kwon OC; Ghang B; Lee EJ; Hong S; Lee CK; Yoo B; Kim S; Kim YG
Int J Rheum Dis; 2019 Jul; 22(7):1305-1311. PubMed ID: 30941928
[TBL] [Abstract][Full Text] [Related]
15. Soluble TNF-R1, VEGF and other cytokines as markers of disease activity in systemic lupus erythematosus and lupus nephritis.
Adhya Z; El Anbari M; Anwar S; Mortimer A; Marr N; Karim MY
Lupus; 2019 May; 28(6):713-721. PubMed ID: 31046570
[TBL] [Abstract][Full Text] [Related]
16. Association of anti-nuclesome and anti C1q antibodies with lupus nephritis in an Egyptian cohort of patients with systemic lupus erythematosus.
Metwally IM; Eesa NN; Yacoub MH; Elsman RM
Adv Rheumatol; 2019 Mar; 59(1):10. PubMed ID: 30832710
[TBL] [Abstract][Full Text] [Related]
17. Promising Roles of Exosomal microRNAs in Systemic Lupus Erythematosus.
Wang W; Yue C; Gao S; Li S; Zhou J; Chen J; Fu J; Sun W; Hua C
Front Immunol; 2021; 12():757096. PubMed ID: 34966383
[TBL] [Abstract][Full Text] [Related]
18. [Osteopontin in systemic lupus erythematosus].
Kitagori K; Yoshifuji H
Nihon Rinsho Meneki Gakkai Kaishi; 2017; 40(2):118-123. PubMed ID: 28603202
[TBL] [Abstract][Full Text] [Related]
19. Urinary dedifferentiated podocytes as a non-invasive biomarker of lupus nephritis.
Perez-Hernandez J; Olivares MD; Forner MJ; Chaves FJ; Cortes R; Redon J
Nephrol Dial Transplant; 2016 May; 31(5):780-9. PubMed ID: 26932688
[TBL] [Abstract][Full Text] [Related]
20. Identification of long non-coding RNAs GAS5, linc0597 and lnc-DC in plasma as novel biomarkers for systemic lupus erythematosus.
Wu GC; Li J; Leng RX; Li XP; Li XM; Wang DG; Pan HF; Ye DQ
Oncotarget; 2017 Apr; 8(14):23650-23663. PubMed ID: 28423570
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
